[Sodium carbenoxolone].
D002986:Clinical Trials as Topic; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006035:Glycyrrhiza; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy*; D010946:Plants, Medicinal; D013729:Terpenes / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D013729:Terpenes
Carbenoxolon-Natrium.